Literature DB >> 15710471

Mannosylated PLP(139-151) induces peptide-specific tolerance to experimental autoimmune encephalomyelitis.

Mariken E Luca1, Junda M Kel, Wouter van Rijs, Jan Wouter Drijfhout, Frits Koning, Lex Nagelkerken.   

Abstract

SJL mice immunized with mannosylated (M-) PLP(139-151) in complete adjuvant do not develop EAE and little CNS mononuclear cell infiltration; other mannosylated peptides were ineffective in this experimental setting. Despite apparently normal T cell responses, M-PLP(139-151)-immunized mice show impaired delayed-type-sensitivity to PLP(139-151) but a normal response to other peptides. After re-immunization with PLP(139-151) in complete adjuvant, these mice are largely tolerant to EAE, show less T cell proliferation and decreased peptide-specific IgG2a. Our data suggest that M-PLP(139-151) induces peptide-specific tolerance to EAE via a mechanism of deletion or impaired migration of encephalitogenic T cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15710471     DOI: 10.1016/j.jneuroim.2004.11.014

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  11 in total

1.  Soluble mannosylated myelin peptide inhibits the encephalitogenicity of autoreactive T cells during experimental autoimmune encephalomyelitis.

Authors:  Junda Kel; Judith Oldenampsen; Mariken Luca; Jan Wouter Drijfhout; Frits Koning; Lex Nagelkerken
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

2.  Prophylactic and therapeutic suppression of experimental autoimmune encephalomyelitis by a novel bifunctional peptide inhibitor.

Authors:  Naoki Kobayashi; Paul Kiptoo; Hitomi Kobayashi; Rahmawati Ridwan; Stefan Brocke; Teruna J Siahaan
Journal:  Clin Immunol       Date:  2008-08-03       Impact factor: 3.969

3.  I-domain-antigen conjugate (IDAC) for delivering antigenic peptides to APC: synthesis, characterization, and in vivo EAE suppression.

Authors:  Prakash Manikwar; Barlas Büyüktimkin; Paul Kiptoo; Ahmed H Badawi; Nadezhda A Galeva; Todd D Williams; Teruna J Siahaan
Journal:  Bioconjug Chem       Date:  2012-03-12       Impact factor: 4.774

4.  Mannose receptor induces T-cell tolerance via inhibition of CD45 and up-regulation of CTLA-4.

Authors:  Verena Schuette; Maria Embgenbroich; Thomas Ulas; Meike Welz; Jonas Schulte-Schrepping; Astrid M Draffehn; Thomas Quast; Katharina Koch; Melanie Nehring; Jessica König; Annegret Zweynert; Frederike L Harms; Nancy Steiner; Andreas Limmer; Irmgard Förster; Friederike Berberich-Siebelt; Percy A Knolle; Dirk Wohlleber; Waldemar Kolanus; Marc Beyer; Joachim L Schultze; Sven Burgdorf
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-06       Impact factor: 11.205

5.  Autoantigen Tetramer Silences Autoreactive B Cell Populations.

Authors:  Matthew A Christopher; Stephanie N Johnson; J Daniel Griffin; Cory J Berkland
Journal:  Mol Pharm       Date:  2020-10-06       Impact factor: 4.939

6.  Immune response to controlled release of immunomodulating peptides in a murine experimental autoimmune encephalomyelitis (EAE) model.

Authors:  Hong Zhao; Paul Kiptoo; Todd D Williams; Teruna J Siahaan; Elizabeth M Topp
Journal:  J Control Release       Date:  2009-09-12       Impact factor: 9.776

7.  Generation of hypoallergenic neoglycoconjugates for dendritic cell targeted vaccination: a novel tool for specific immunotherapy.

Authors:  Esther E Weinberger; Martin Himly; Julia Myschik; Michael Hauser; Friedrich Altmann; Almedina Isakovic; Sandra Scheiblhofer; Josef Thalhamer; Richard Weiss
Journal:  J Control Release       Date:  2012-11-10       Impact factor: 9.776

8.  Enhanced cross-presentation and improved CD8+ T cell responses after mannosylation of synthetic long peptides in mice.

Authors:  Judith Rauen; Christoph Kreer; Arlette Paillard; Suzanne van Duikeren; Willemien E Benckhuijsen; Marcel G Camps; A Rob P M Valentijn; Ferry Ossendorp; Jan W Drijfhout; Ramon Arens; Sven Burgdorf
Journal:  PLoS One       Date:  2014-08-19       Impact factor: 3.240

9.  Mannan-MOG35-55 Reverses Experimental Autoimmune Encephalomyelitis, Inducing a Peripheral Type 2 Myeloid Response, Reducing CNS Inflammation, and Preserving Axons in Spinal Cord Lesions.

Authors:  Anastasia Dagkonaki; Maria Avloniti; Maria Evangelidou; Irini Papazian; Ioannis Kanistras; Vivian Tseveleki; Fotis Lampros; Theodore Tselios; Lise Torp Jensen; Wiebke Möbius; Torben Ruhwedel; Maria-Eleni Androutsou; John Matsoukas; Maria Anagnostouli; Hans Lassmann; Lesley Probert
Journal:  Front Immunol       Date:  2020-11-19       Impact factor: 7.561

10.  Liposome-encapsulated peptides protect against experimental allergic encephalitis.

Authors:  Alexey A Belogurov; Alexey V Stepanov; Ivan V Smirnov; Dobroslav Melamed; Andrew Bacon; Azad E Mamedov; Vitali M Boitsov; Lidia P Sashchenko; Natalia A Ponomarenko; Svetlana N Sharanova; Alexey N Boyko; Michael V Dubina; Alain Friboulet; Dmitry D Genkin; Alexander G Gabibov
Journal:  FASEB J       Date:  2012-10-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.